FinTrust Capital Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $2.34K | Hold |
21
| – | – | ﹤0.01% | 1184 |
|
2024
Q2 | $2.24K | Sell |
21
-2
| -9% | -$214 | ﹤0.01% | 1153 |
|
2024
Q1 | $2.77K | Hold |
23
| – | – | ﹤0.01% | 1051 |
|
2023
Q4 | $2.83K | Hold |
23
| – | – | ﹤0.01% | 1019 |
|
2023
Q3 | $2.98K | Hold |
23
| – | – | ﹤0.01% | 951 |
|
2023
Q2 | $3.67K | Hold |
23
| – | – | ﹤0.01% | 918 |
|
2023
Q1 | $3.67K | Hold |
23
| – | – | ﹤0.01% | 913 |
|
2022
Q4 | $3.66K | Buy |
23
+16
| +229% | +$2.55K | ﹤0.01% | 916 |
|
2022
Q3 | $1K | Hold |
7
| – | – | ﹤0.01% | 1168 |
|
2022
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 1169 |
|
2022
Q1 | $1K | Sell |
7
-78
| -92% | -$11.1K | ﹤0.01% | 1171 |
|
2021
Q4 | $11K | Sell |
85
-44
| -34% | -$5.69K | ﹤0.01% | 895 |
|
2021
Q3 | $17K | Sell |
129
-5
| -4% | -$659 | ﹤0.01% | 768 |
|
2021
Q2 | $24K | Buy |
134
+12
| +10% | +$2.15K | 0.01% | 700 |
|
2021
Q1 | $20K | Sell |
122
-36
| -23% | -$5.9K | 0.01% | 709 |
|
2020
Q4 | $26K | Buy |
+158
| New | +$26K | 0.01% | 608 |
|